Your browser doesn't support javascript.
loading
Establishment of an in vivo model for duck hepatitis B virus infection using Hubei duckling / 中华实验和临床病毒学杂志
Chinese Journal of Experimental and Clinical Virology ; (6): 113-115, 2008.
Artigo em Chinês | WPRIM | ID: wpr-254127
ABSTRACT
<p><b>OBJECTIVE</b>To develop a standard duck hepatitis B virus (DHBV) animal model using a local Hubei species of duck, Ma Ya, and use it as an in vivo experimental system to study antiviral strategies against hepatitis B.</p><p><b>METHODS</b>Two-day-old Ma Ya ducklings were experimentally infected via intraperitoneal injection with the DHBV inocula which was collected from the transfected culture supernatant of 1.5-fold-overlength genome recombinant plasmid. Blood samples were taken twice or thrice a week during post-inoculation for 50 days. Viremia was quantified by serum real-time PCR to show the peak. Antiviral treatment of the DHBV-infected ducklings was started 3 d post-inoculation. The animals received oral administration of lamivudine (3TC) at a dose of 25 mg/kg/d for 5 d, followed by a maintenance therapy thrice weekly for 3 more weeks. Serum was quantified to show the viremia peak and liver biopsy specimens were analysed by Southern blotting and in-situ hybridization at the end of antiviral drug treatment.</p><p><b>RESULTS</b>The experimental infection rate of 2-day-old ducklings was 87.5%. Viremia started to be detectable on day 7 and reached a peak on day 11 post-inoculation, followed by a decrease and fluctuations. Four weeks of oral administration of 3TC led to a significant decrease in viremia peak during. This effect was not sustained, as a rebound in viremia was observed after drug withdrawal. Similarly, the analysis of liver biopsies at the end of 3TC treatment showed a marked decrease in DHBV DNA. However, after drug withdrawal a rebound of intrahepatic DHBV DNA was observed in duck livers.</p><p><b>CONCLUSION</b>The Hubei duck model with experimental DHBV infection of transfected supernatant is more suitable for the hepadnavirus biologic research due to its stability and practicability.</p>
Assuntos
Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Patologia / Farmacologia / Viremia / Virologia / Sangue / DNA Viral / Vírus da Hepatite B do Pato / Infecções por Hepadnaviridae / Inibidores da Transcriptase Reversa / Lamivudina Limite: Animais Idioma: Chinês Revista: Chinese Journal of Experimental and Clinical Virology Ano de publicação: 2008 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Patologia / Farmacologia / Viremia / Virologia / Sangue / DNA Viral / Vírus da Hepatite B do Pato / Infecções por Hepadnaviridae / Inibidores da Transcriptase Reversa / Lamivudina Limite: Animais Idioma: Chinês Revista: Chinese Journal of Experimental and Clinical Virology Ano de publicação: 2008 Tipo de documento: Artigo